Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinling Pharmaceutical is a China-based listed pharmaceutical company headquartered in Nanjing that manufactures and sells traditional Chinese medicine, chemical drugs, APIs, medical devices, and related healthcare products. Its marketed portfolio includes Mailuoning injection/oral solutions, ferrous succinate tablets, lentinan injection, absorbent gelatin sponges, and other hospital-facing products. Beyond pharma manufacturing, the company also operates medical and health services through hospitals, elder-care facilities, rehabilitation, and welfare centers. The business appears focused primarily on the domestic Chinese market and is best characterized as a commercial-stage diversified pharma and healthcare operator rather than an innovation-driven biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Jinling.